Important Notice from the EDQM to CEP Holders - Warning of Fraudulent Invoices
![Stability Studies to Support Shipping/Distribution of Pharmaceuticals and Biopharmaceuticals - Live Online Training](files/eca/userImages/training.img/Z-ECA-Stability-Studies-Shipping-Distribution-LOT.jpg)
Recommendation
12/13 September 2024
In a press release from 21 May 2012, the EDQM (European Directorate for the Quality of Medicines & HealthCare), declared that some CEP holders may have recently received an invoice from an organisation which calls itself "Directory for Certificates of Suitability" (DCEP), asking them to pay a fee to include their CEPs in a "Directory".
The EDQM expressly states that these invoices haven't been sent by the EDQM and that holders of CEPs do not require their CEPs to be registered in any directory.
Find more information on the EDQM Website and in the press release.
Author:
Dr Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
24.07.2024FDA Warning Letter to Chinese OTC Manufacturer for Lack of Analytical Test Data
10.07.2024Pharmeuropa: Two Revised Chapters on Dissolution Testing published for comments
03.07.2024FDA Warning Letter: GMP Requirements also apply to HPLC Analyses for Internal Use
12.06.2024NMPA Announcement on Application of ICH Q2(R2) and Q14 Principles
22.05.2024Q&As from the Live Online Training "Introduction to the AQCG's new AIQSV Guide" - Part 1
22.05.2024FDA Warning Letter to Contract Testing Laboratory in Uruguay due to Data Integrity Violations